The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition
Sherene Loi, Stefan Michiels, Sylvia Adams, Sibylle Loibl, Jan Budczies, Carsten Denkert, Roberto Salgado
Topics & Concepts
MedicineBreast cancerTumor-infiltrating lymphocytesOncologyTriple-negative breast cancerBiomarkerH&E stainInternal medicineCancerStage (stratigraphy)ImmunotherapyImmunohistochemistryBiologyPaleontologyBiochemistryChemistryCancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesCancer Cells and Metastasis